Breast Cancer Clinical Trial
Adherence of Hispanic / Latina Breast Cancer – Patients to Adjuvant Aromatase Inhibitors
Summary
This is an observational trial designed to assess prospectively the adherence rate to AIs among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant therapy after standard local and systemic therapy. We will study adherence by administrating the 8-item Morisky Medication Adherence Scale (MMAS - 8).
Full Description
Women with breast cancer seen at the Texas Tech Physicians Breast Care Center will be recruited during their routine follow-up visit with their medical oncologist.
Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
Patients must be on one of AI (steroidal or non-steroidal).
Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery.
Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish.
Eligibility Criteria
Inclusion Criteria:
Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery.
Patient must be on one of AI (steroidal or non-steroidal).
Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish
Exclusion Criteria:
< 18 years old
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
El Paso Texas, 79905, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.